| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 24 Mar 2026 | 17 Mar 2026 |
| Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/03/2026 inter alia to consider and approve This is to inform you that meeting of the Board of Directors of the Company will be held on Tuesday March 24 2026 at Shri 1st Floor Opp Satyasai Heart Hospital Narayan Nagar Kalawad Road Kankot Rajkot Gujarat India 360005 to consider inter alia a proposal for: 1. Increase in Authorized Share Capital subject to approval of members of the Company. 2. Consideration and recommendation of Bonus Equity Shares subject to approval of Members of the Company. Trading Window for dealing in the securities of the Company for all the Designated Persons and their immediate relatives will remain closed with effect from Wednesday 18th March 2026 Thursday March 26 2026 (both days inclusive) for aforesaid consideration/recommendation of the Board of Directors of the Company. Board considered and approved the following matters:- 1. Increase in Authorized Share Capital Approved the proposal for increase in Authorized Share Capital of the Company from INR. 7,15,00,000/- (Rupees Seven Crores Fifteen Lakhs Only) comprising 71,50,000 (Seventy-One Lakh Fifty Thousand) equity shares of Rs. 10 (Rupees Ten) to INR 25,00,00,000/- (Rupees Twenty-Five Crores Only) divided into 2,50,00,000 (Rupees Two Crores Fifty Lakhs Only) equity shares of Rs. 10 (Rupees Ten) each subject to approval of the Members of the Company. 2. Recommendation of Bonus Equity Shares Considered and recommended issue of Bonus Equity Shares in the ratio of 3:2 i.e. 3 (Three) bonus equity shares for every 2 (Two) existing fully paid-up equity share held by the Members of the Company, subject to approval of Members of the Company. 3. Approval of Postal Ballot Notice Approved the draft Postal Ballot Notice along with explanatory statement to seek approval of the Members of the Company for: Increase in Authorized Share Capital Issue of Bonus Equity Shares through Postal Ballot by way of remote e-voting. The Board has also: Appointed Scrutinizer for conducting the postal ballot process in a fair and transparent manner Approved cut-off date, e-voting period, and related matters Authorized officials of the Company to complete necessary formalities in this regard 4. Appointment of E-voting Agency Approved appointment of Central Depository Systems Limited (CDSL) as the agency for providing remote e-voting facility for the Postal Ballot process (As Per BSE Bulletin Dated on 24.03.2026). Revised outcome of Board Meeting held on 24/03/2026 incorporating additional details in compliance with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. (As per BSE announcement dated on : 26.03.2026) | ||
| Board Meeting | 10 Nov 2025 | 1 Nov 2025 |
| Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 inter alia to consider and approve To Consider and take on Record of the Un-Audited Financial results for the half year ended on 30th September 2025. Board Meeting Outcome for Approval Of Unaudited Financial Results For The Half Year Ended on 30th September, 2025 Unaudited Financial Results for the half year ended on 30th September, 2025 (As Per BSE Announcement Dated on:10.11.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
